Fluence Partners with Phaneros Institute to Advance Psychedelic Therapy Training in Brazil

MEDIA CONTACT:
Brad Burge
brad@integrationcommunications.com

Fluence, a leading psychedelic therapy training company, is proud to announce a new partnership with the Phaneros Institute, a Brazilian non-profit research organization focused on bringing psychedelic-assisted psychotherapy to the Brazilian healthcare system.

Under this landmark agreement, the Phaneros Institute will have unlimited access to Fluence's comprehensive educational content via its online learning management system. Fluence will also provide a version of its training materials translated into Brazilian Portuguese to cater to the institute's needs.

Established in 2011 by Eduardo Schenberg, PhD, Phaneros Institute is at the forefront of psychedelic-assisted psychotherapy research in Brazil. It recently completed a pilot study of MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) and is now working towards gaining approval for further studies to accelerate the availability of psychedelic therapies in Brazil.

"We are delighted to be working with Phaneros Institute, helping to bring psychedelic therapy into mainstream healthcare in Brazil," said Fluence co-founder Elizabeth Nielson, PhD. "Our partnership will give Phaneros the tools it needs to train therapists effectively, resulting in wider dissemination of research-based psychedelic therapy practice. "

“We’re happy to jointly launch a ketamine therapy course in Brazil with Fluence,” said Phaneros founder Eduardo Schenberg, PhD. “We already see our clinicians being challenged on how to best support patients, whether with off-label racemic ketamine or intranasal esketamine for depression, which is approved by the Brazilian regulatory authority ANVISA. This course will be of interest to many clinicians and, we hope, will improve the safety and effectiveness of ketamine sessions in Brazil.”

As part of the partnership, Fluence will provide ongoing technical assistance to Phaneros in the development and execution of their MDMA-assisted therapy training program. This is targeted at Brazilian therapists who will work in the research program and, subject to approval, in the provision of MDMA-assisted psychotherapy to the public.

Furthermore, Fluence will offer consultation and assistance on research therapy manual and study design, including training studies for healthy volunteers and clinical population studies. Fluence will also take an active role in educating clinicians about Phaneros's training and research programs through guest lectures and webinars featuring researchers from the Phaneros Institute.

More information on the partnership (in Portuguese) is available here.

Fluence is a leading psychedelic therapy training company that provides comprehensive, evidence-based training to clinicians and other professionals who want to provide psychedelic therapy. Fluence’s training programs are designed to prepare clinicians to safely and effectively administer psychedelic-assisted therapies, and to provide them with the skills and knowledge they need to integrate these therapies into their practice. In addition to providing expert-driven training for individual practitioners and research organizations, Fluence has been selected by the State of Oregon as a state-licensed provider of training for licensed facilitators of psilocybin services.

The non-profit Phaneros Institute is one of the leading organizations in the field of psychedelic research in Brazil. Founded in 2011, the institute's mission is to promote the development of psychedelic-assisted psychotherapies for the treatment of mental disorders. The institute conducts research on the efficacy and safety of psychedelic-assisted psychotherapies, provides psychedelic therapy training to healthcare professionals, and advocates for policies supporting psychedelics for medical use.